Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion
Authors:
- Kyriakos AnastasiadisKAKyriakos Anastasiadis
- Polychronis AntonitsisPAPolychronis Antonitsis
- Helena ArgiriadouHAHelena Argiriadou
- Georgios KoliakosGKGeorgios Koliakos
- Argyrios DoumasADArgyrios Doumas
- Andre KhayatAKAndre Khayat
- Christos PapakonstantinouCPChristos Papakonstantinou
- Stephen WestabySWStephen Westaby
Open Access
- 19 January 2011
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 9 (1) , 12
Abstract
We challenge the hypothesis of enhanced myocardial reperfusion after implanting a left ventricular assist device together with bone marrow mononuclear stem cells in patients with end-stage ischemic cardiomyopathy. Irreversible myocardial loss observed in ischemic cardiomyopathy leads to progressive cardiac remodelling and dysfunction through a complex neurohormonal cascade. New generation assist devices promote myocardial recovery only in patients with dilated or peripartum cardiomyopathy. In the setting of diffuse myocardial ischemia not amenable to revascularization, native myocardial recovery has not been observed after implantation of an assist device as destination therapy. The hybrid approach of implanting autologous bone marrow stem cells during assist device implantation may eventually improve native cardiac function, which may be associated with a better prognosis eventually ameliorating the need for subsequent heart transplantation. The aforementioned hypothesis has to be tested with well-designed prospective multicentre studies.Keywords
This publication has 26 references indexed in Scilit:
- Destination therapy with a rotary blood pump and novel power delivery☆European Journal of Cardio-Thoracic Surgery, 2009
- Combined autologous cellular cardiomyoplasty using skeletal myoblasts and bone marrow cells for human ischemic cardiomyopathy with left ventricular assist system implantation: Report of a caseSurgery Today, 2009
- Increased Expression of Stem Cell Factor and Its Receptor After Left Ventricular Assist Device Support: A Potential Novel Target for Therapeutic Interventions in Heart FailureThe Journal of Heart and Lung Transplantation, 2008
- Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling processProgress in Biophysics and Molecular Biology, 2008
- Left ventricular assist device-induced molecular changes in the failing myocardiumCurrent Opinion in Cardiology, 2008
- Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actionsFEBS Letters, 2007
- Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart FailureNew England Journal of Medicine, 2006
- Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarctsNature, 2004
- Bridging-to-recoveryThe Annals of Thoracic Surgery, 2001
- The hibernating myocardiumAmerican Heart Journal, 1989